Thomas Relander

1 – 10 of 40

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/5449922a-67d1-4855-bc51-3dc95323c6db?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
next »

2024
Mark The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
Bhansali, R.S. ; Relander, T. ^LU ; Jerkeman, M. ^LU and Barta, S.K. (2024) In Blood Advances 8(13). p.3507-3518
- Contribution to journal › Article
Mark Ovanligt symtom med hög klinisk valör vid Hodgkins lymfom
Lanke, Elsa and Relander, Thomas ^LU (2024) In Lakartidningen 121.
- Contribution to journal › Article
2022
Mark Identifying causal relationships of cancer treatment and long-term health effects among 5-year survivors of childhood cancer in Southern Sweden
Holst, Anders ; Ekman, Jan ; Petersson-Ahrholt, Magnus ; Relander, Thomas ^LU ; Wiebe, Thomas ^LU and Linge, Helena M ^LU (2022) In Communications medicine 2. p.1-12
- Contribution to journal › Article
Mark Impact of comorbidity in older patients with peripheral T-cell lymphoma : an international retrospective analysis of 891 patients
Mead, Monica ; Cederleuf, Henrik ^LU ; Bjorklund, Maja ; Wang, Xiaoyan ; Relander, Thomas ^LU ; Jerkeman, Mats ^LU ; Gaut, Daria ; Larson, Sarah and Ellin, Fredrik ^LU (2022) In Blood Advances 6(7). p.2120-2128
- Contribution to journal › Article
2021
Mark Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma : the DSHNHL2006-1B/ACT-2 trial
Wulf, Gerald G. ; Altmann, Bettina ; Ziepert, Marita ; D’Amore, Francesco ; Held, Gerhard ; Greil, Richard ; Tournilhac, Olivier ; Relander, Thomas ^LU ; Viardot, Andreas and Wilhelm, Martin , et al. (2021) In Leukemia 35(1). p.143-155
- Contribution to journal › Article
Mark Hudlymfom – ovanlig sjukdom ofta med lång tid till diagnos
Belfrage, Emma ^LU ; Relander, Thomas ^LU and Brauner, Hanna (2021) In Lakartidningen 118.
- Contribution to journal › Article
2019
Mark Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas
Ellin, Fredrik ^LU ; Maurer, Matthew J. ; Srour, Line ; Farooq, Umar ; Jerkeman, Mats ^LU ; Connors, Joseph M. ; Smedby, Karin E. ; Bennani, N. Nora ; Ansell, Stephen M. and Slack, Graham W. , et al. (2019) In British Journal of Haematology 186(3). p.24-27
- Contribution to journal › Debate/Note/Editorial
Mark Development and Implementation of Survivorship Tools to Enable Medical Follow-Up After Childhood Cancer Treatment in Southern Sweden
Petersson-Ahrholt, Magnus ; Wiebe, Thomas ^LU ; Hjorth, Lars ^LU ; Relander, Thomas ^LU and Linge, Helena M ^LU (2019) In JCO clinical cancer informatics 3. p.1-6
- Contribution to journal › Article
2018
Mark Impact of comorbidity on survival in peripheral T-cell lymphomas : A Swedish Lymphoma Registry study
Ellin, Fredrik ^LU ; Jerkeman, Mats ^LU ; Törnqvist, Jenny ; Brudin, Lars and Relander, Thomas ^LU (2018) In Hematological Oncology 36(1). p.159-165
- Contribution to journal › Article
Mark Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
Kwong, Y. L. ; Kim, S. J. ; Tse, E. ; Oh, S. Y. ; Kwak, J. Y. ; Eom, H. S. ; Do, Y. R. ; Mun, Y. C. ; Lee, S. R. and Shin, H. J. , et al. (2018) In Annals of Oncology 29(1). p.256-263
- Contribution to journal › Article

« previous
1
2
3
4
next »